SCHEMBL2897766

SCHEMBL2897766

CCCCCCCC/C=C\CCCCCCCC(=O)C(=O)C(F)(F)F

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FAAH O00519 7/20 0.70
CES1 P23141 2/20 0.70
FABP3 P05413 5/20 0.61
TERT O14746 3/20 0.58
CYP1A2 P05177 2/20 0.58
MAPT P10636 2/20 0.58
CYP2C19 P33261 2/20 0.58
BLM P54132 2/20 0.58
HSD17B10 Q99714 2/20 0.58
FABP4 P15090 2/20 0.58
PTPN1 P18031 2/20 0.58
PPARG P37231 2/20 0.58
KMT2A Q03164 2/20 0.58
PPARD Q03181 2/20 0.58
PPARA Q07869 2/20 0.58
GMNN O75496 1/20 0.58
USP2 O75604 1/20 0.58
LMNA P02545 1/20 0.58
POLB P06746 1/20 0.58
CYP2C9 P11712 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2897767 1.00 FAAH (0.70) FAAHCES1FABP3TERTCYP1A2
SCHEMBL2827382 0.90 FAAH (0.71) FAAHCES1FABP3MAPTBLM
SCHEMBL29794313 0.89 CES1 (0.63) FAAHCES1CYP1A2HSD17B10KMT2A
SCHEMBL1334928 0.89 CES1 (0.63) FAAHCES1CYP1A2HSD17B10KMT2A
SCHEMBL20600305 0.83 FAAH (0.78) FAAHFABP3TERTCYP1A2MAPT
SCHEMBL15400706 0.83 FAAH (0.78) FAAHFABP3TERTCYP1A2MAPT
SCHEMBL24938529 0.82 FAAH (1.00) FAAHCES1TERTCYP1A2MAPT
SCHEMBL4085373 0.82 FAAH (1.00) FAAHCES1TERTCYP1A2MAPT
SCHEMBL24938531 0.82 FAAH (1.00) FAAHCES1TERTCYP1A2MAPT
SCHEMBL8059738 0.82 FAAH (1.00) FAAHCES1TERTCYP1A2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1370867-B1 PROTEIN PROFILING PLATFORM ACTIVX BIOSCIENCES INC (US) 2010-08-04 EP disclosed
CN-101528770-A Methods of preparation of recombinant forms of human beta-amyloid protein and uses of these proteins ABBOTT LAB (US) 2009-09-09 CN disclosed
US-7179655-B2 Protein profiling platform ACTIVX BIOSCIENCES, INC. (US) 2007-02-20 US disclosed
US-20050287594-A1 Activity-based probes having specificity to the active form of enzymes and receptors; screening for desired biological activities or target proteins SCRIPPS RESEARCH INSTITUTE, THE 2005-12-29 US disclosed
US-6872574-B2 Generating and screening compound libraries that are used for the identification of lead molecules, and for the parallel identification of their biological targets THE SCRIPPS RESEARCH INSTITUTE (US) 2005-03-29 US disclosed
EP-1370867-A4 PROTEIN PROFILING PLATFORM ACTIVX BIOSCIENCES INC (US) 2005-01-26 EP disclosed
EP-1370867-A1 PROTEIN PROFILING PLATFORM Activx Biosciences, Inc. (US) 2003-12-17 EP disclosed
EP-1275006-A2 PROTEOMIC ANALYSIS USING ACTIVITY-BASED PROBE LIBRARIES The Scripps Research Institute (US) 2003-01-15 EP disclosed
US-20020182651-A1 Protein profiling platform ACTIVX BIOSCIENCES, INC. 2002-12-05 US disclosed
US-20020182652-A1 Proteomic analysis NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR 2002-12-05 US disclosed
WO-2002071066-A1 PROTEIN PROFILING PLATFORM ACTIVX BIOSCIENCES, INC. (US) 2002-09-12 WO disclosed
US-20020064799-A1 Proteomic analysis THE SCRIPPS RESEARCH INSTITUTE OF AN ASSIGNMENT 2002-05-30 US disclosed
US-20020045194-A1 Proteomic analysis NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2002-04-18 US disclosed
US-20020040275-A1 Proteomic analysis THE SCRIPPS RESEARCH INSTITUTE 2002-04-04 US disclosed
WO-2001077668-A2 PROTEOMIC ANALYSIS USING ACTIVE-SITE DIRECTED PROBES THE SCRIPPS RESEARCH INSTITUTE (US) 2001-10-18 WO disclosed
WO-2001077684-A2 PROTEOMIC ANALYSIS USING ACTIVITY-BASED PROBE LIBRARIES THE SCRIPPS RESEARCH INSTITUTE (US) 2001-10-18 WO disclosed